MBD4 and Wilson disease: In summary, introducing a larger amino acid (Asp or Val instead of Gly) at position 386 in MBD4 (as found in MBD1 and MBD6 in Wilson disease patients) results in enhanced domain structural dynamics in silico and decreased resistance towards thermal perturbations in vitro.